Search research articles
Contact Us
Filters
Showing results (11-20 of 65) with videos related to
Page
of 7
Sort By:
Leukemia & Lymphoma
|
November 18, 2024
Infections during novel myeloma therapies
Alice J Liu, Monica A Slavin, Simon J Harrison, et al.
Current Opinion in Infectious Diseases
|
May 2, 2026
Antiviral prophylaxis against herpesviruses (herpes simplex virus, varicella-zoster virus and cytomegalovirus) among patients with cancer
Alice J Liu, Violet Z Zhu, Benjamin W Teh, et al.
Leukemia & Lymphoma
|
September 9, 2023
Recommendations on prevention of infections in patients with T-cell lymphomas: a narrative review and synthesis
Gemma Reynolds, Mary Ann Anderson, Karin Thursky, et al.
Blood Reviews
|
May 1, 2018
Infections in patients with chronic lymphocytic leukaemia: Mitigating risk in the era of targeted therapies
Benjamin W Teh, Constantine S Tam, Sasanka Handunnetti, et al.
BMJ Open
|
May 7, 2026
Longitudinal real-world surveillance of infection outcomes in CAR-T and bispecific therapy recipients: the CLARITY study protocol
Gemma K Reynolds, Mary Ann Anderson, Karin Thursky, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
December 10, 2014
Risks and burden of viral respiratory tract infections in patients with multiple myeloma in the era of immunomodulatory drugs and bortezomib: experience at an Australian Cancer Hospital
Benjamin W Teh, Leon J Worth, Simon J Harrison, et al.
Mycoses
|
September 5, 2020
Low rates of invasive fungal disease in patients with multiple myeloma managed with new generation therapies: Results from a multi-centre cohort study
Chhay Lim, Priyadarshini Sinha, Simon J Harrison, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
March 16, 2021
Epidemiology and Risks of Infections in Patients With Multiple Myeloma Managed With New Generation Therapies
Chhay Lim, Priyadarshini Sinha, Simon J Harrison, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 5, 2016
Infection risk with immunomodulatory and proteasome inhibitor-based therapies across treatment phases for multiple myeloma: A systematic review and meta-analysis
Benjamin W Teh, Simon J Harrison, Leon J Worth, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
October 12, 2017
Safety and cost benefit of an ambulatory program for patients with low-risk neutropenic fever at an Australian centre
Benjamin W Teh, Christine Brown, Trish Joyce, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 65) with videos related to
Sort By:
Page
of 7
Leukemia & Lymphoma
|
November 18, 2024
Infections during novel myeloma therapies
Alice J Liu, Monica A Slavin, Simon J Harrison, et al.
Current Opinion in Infectious Diseases
|
May 2, 2026
Antiviral prophylaxis against herpesviruses (herpes simplex virus, varicella-zoster virus and cytomegalovirus) among patients with cancer
Alice J Liu, Violet Z Zhu, Benjamin W Teh, et al.
Leukemia & Lymphoma
|
September 9, 2023
Recommendations on prevention of infections in patients with T-cell lymphomas: a narrative review and synthesis
Gemma Reynolds, Mary Ann Anderson, Karin Thursky, et al.
Blood Reviews
|
May 1, 2018
Infections in patients with chronic lymphocytic leukaemia: Mitigating risk in the era of targeted therapies
Benjamin W Teh, Constantine S Tam, Sasanka Handunnetti, et al.
BMJ Open
|
May 7, 2026
Longitudinal real-world surveillance of infection outcomes in CAR-T and bispecific therapy recipients: the CLARITY study protocol
Gemma K Reynolds, Mary Ann Anderson, Karin Thursky, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
December 10, 2014
Risks and burden of viral respiratory tract infections in patients with multiple myeloma in the era of immunomodulatory drugs and bortezomib: experience at an Australian Cancer Hospital
Benjamin W Teh, Leon J Worth, Simon J Harrison, et al.
Mycoses
|
September 5, 2020
Low rates of invasive fungal disease in patients with multiple myeloma managed with new generation therapies: Results from a multi-centre cohort study
Chhay Lim, Priyadarshini Sinha, Simon J Harrison, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
March 16, 2021
Epidemiology and Risks of Infections in Patients With Multiple Myeloma Managed With New Generation Therapies
Chhay Lim, Priyadarshini Sinha, Simon J Harrison, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 5, 2016
Infection risk with immunomodulatory and proteasome inhibitor-based therapies across treatment phases for multiple myeloma: A systematic review and meta-analysis
Benjamin W Teh, Simon J Harrison, Leon J Worth, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
October 12, 2017
Safety and cost benefit of an ambulatory program for patients with low-risk neutropenic fever at an Australian centre
Benjamin W Teh, Christine Brown, Trish Joyce, et al.
Page
of 7